-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

-Frontline It is the goal of social revolution that connects the aam aadmi to the judiciary and to its highest institution, the Supreme Court of India. By Prof. G. MOHAN GOPAL WHAT should be the appropriate mea-sure of the relationship between the apex court of a country and its common people? Should an apex court be evaluated by who invokes its jurisdiction, from which area and for what purpose? Is an apex...

-Frontline   The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...

-PTI Jamshedpur: free legal aid Committee (FLAC), an NGO engaged in spreading awareness against superstition of daayan (witch), demanded a ban on Emraan Hashmi's film Ek Thi Daayan. Kannan Iyer's Ek Thi Daayan, a supernatural film, features Emraan Hashmir, Huma Qureshi, Konkona Sen Sharma and Kalki Koechlin. Prem Chand alias Premji of FLAC, said he had recently written a letter to President Pranab Mukherjee demanding immediate ban on the film as...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...